In recent years, Tau has represented a focus of interest since it is primarily involved in many neurodegenerative diseases (among them, Alzheimer's disease), commonly defined as tauopathies (Gerson et al., 2016; Kovacs, 2017). This evidence concerns the gene MAPT and tauopathy.